Table 3.
The efficacy in neoadjuvant chemotherapy subgroups
| n | Clinically effective | Clinically ineffective | p | χ2 | |
|---|---|---|---|---|---|
| IA-NAC+ RS | 40 | 15 (37.5%) | 25 (62.5%) | 0.192 | 1.704 |
| IV-NAC+ RS | 63 | 16 (25.4%) | 47 (74.6%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.